2022
DOI: 10.1080/14737175.2022.2106854
|View full text |Cite
|
Sign up to set email alerts
|

Current perspectives on the diagnosis and management of fatigue in multiple sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(20 citation statements)
references
References 148 publications
0
11
0
Order By: Relevance
“…The symptom of fatigue is a signi cant lack of physical and/or mental energy that is perceived by the individual to interfere with usual or desired activity. It is a subjective feeling of physical, cognitive or psychosocial exhaustion and tiredness, which can be perceived by the patients at rest 33 . Fatigue in MS has a prevalence of up to 81% being more frequent in the progressive forms of disease 34 .…”
Section: Discussionmentioning
confidence: 99%
“…The symptom of fatigue is a signi cant lack of physical and/or mental energy that is perceived by the individual to interfere with usual or desired activity. It is a subjective feeling of physical, cognitive or psychosocial exhaustion and tiredness, which can be perceived by the patients at rest 33 . Fatigue in MS has a prevalence of up to 81% being more frequent in the progressive forms of disease 34 .…”
Section: Discussionmentioning
confidence: 99%
“…Fatigue is one of the most common and disabling multiple sclerosis (MS) symptoms, but has no effective treatment options. 1 A recent randomized, doubleblind, placebo-controlled crossover trial of the comparative effectiveness of commonly prescribed treatments for fatigue, including amantadine, modafinil, and methylphenidate, found no significant differences in mean Modified Fatigue Impact Scale (MFIS) score between these treatments and placebo. 2 A dietary intervention to improve fatigue in people with MS (PwMS) is highly desirable given the low risk of adverse events and the potential to improve other parameters of a person's health, such as body mass index (BMI) and metabolic profile.…”
Section: Introductionmentioning
confidence: 99%
“…Fatigue is one of the most common and disabling multiple sclerosis (MS) symptoms, but has no effective treatment options. 1 A recent randomized, double-blind, placebo-controlled crossover trial of the comparative effectiveness of commonly prescribed treatments for fatigue, including amantadine, modafinil, and methylphenidate, found no significant differences in mean Modified Fatigue Impact Scale (MFIS) score between these treatments and placebo. 2…”
Section: Introductionmentioning
confidence: 99%
“…7 Research results show that 70%-90% of patients with MS suffer from fatigue. 8 Despite the medical advances in recent years, there is currently no definitive treatment for MS, and most of the existing treatment approaches only lead to reduced symptoms or shorten the course of the disease. Meanwhile, it seems that exercise can be used as a complementary treatment along with pharmaceutical approaches.…”
mentioning
confidence: 99%
“…This fatigue affects the movement and cognitive ability of the patient and can seem as a decrease in energy, feeling unwell, movement weakness, and difficulty in maintaining concentration 7 . Research results show that 70%–90% of patients with MS suffer from fatigue 8 …”
mentioning
confidence: 99%